UK Antiviral Drugs Market Size & Outlook, 2022-2030
UK antiviral drugs market, 2018-2030 (US$M)
Related Markets
UK antiviral drugs market highlights
- The UK antiviral drugs market generated a revenue of USD 5,606.2 million in 2022 and is expected to reach USD 5,153.2 million by 2030.
- The UK market is expected to grow at a CAGR of -1% from 2023 to 2030.
- In terms of segment, hiv was the largest revenue generating application in 2022.
- Herpes is the most lucrative application segment registering the fastest growth during the forecast period.
Antiviral drugs market data book summary
| Market revenue in 2022 | USD 5,606.2 million |
| Market revenue in 2030 | USD 5,153.2 million |
| Growth rate | -1% (CAGR from 2022 to 2030) |
| Largest segment | Hiv |
| Fastest growing segment | Herpes |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | HIV, Hepatitis, Herpes, Influenza |
| Key market players worldwide | Roche Holding AG, GSK PLC ADR, AbbVie Inc, Merck & Co Inc, Johnson & Johnson, Bristol-Myers Squibb Co, Dr Reddy's Laboratories Ltd ADR, Aurobindo Pharma |
Other key industry trends
- In terms of revenue, UK accounted for 7.7% of the global antiviral drugs market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany antiviral drugs market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 5,153.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antiviral Drugs Market Scope
Antiviral Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK antiviral drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiviral drugs market will help companies and investors design strategic landscapes.
Hiv was the largest segment with a revenue share of 34.33% in 2022. Horizon Databook has segmented the UK antiviral drugs market based on hiv, hepatitis, herpes, influenza covering the revenue growth of each sub-segment from 2018 to 2030.
The antiviral drugs market in the UK is one of the major markets in the region. With the increasing prevalence of viral infections and the growing need for therapeutics, regional players are engaged in developing effective and economical treatment therapeutics, fueling market growth in the country.
Major players are investing in pharma R&D to develop novel therapeutics, which is expected to fuel market growth in the country. Key initiatives undertaken in the country include the steps taken to revolutionize treatment. Favorable government initiatives and increased R&D activities in the country are driving market growth.
In addition, the high disease burden and significant government interventions in spreading awareness regarding various viral diseases are some of the factors driving the market. Moreover, presence of an established healthcare system, high disposable income, rise in awareness about early diagnosis of diseases, and an increasing incidence of antibiotic-resistant infections are expected to drive market growth in the country.
Reasons to subscribe to UK antiviral drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK antiviral drugs market databook
-
Our clientele includes a mix of antiviral drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK antiviral drugs market , including forecasts for subscribers. This country databook contains high-level insights into UK antiviral drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK antiviral drugs market size, by application, 2018-2030 (US$M)
UK Antiviral Drugs Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
